RESTANA

USPTO USPTO 2007 IR CANCELLED; US REGISTRATION CANCELLED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark RESTANA was filed as Word mark on 12/07/2007 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 10/06/2009. The current status of the mark is "IR CANCELLED; US REGISTRATION CANCELLED".

Trademark Details

Trademark form Word mark
File reference 79049152
Register number 3692659
Application date December 7, 2007
Publication date July 21, 2009
Entry date October 6, 2009

Trademark owner

Gewerbestrasse 16
CH4123 Allschwil
CH

Trademark representatives

goods and services

5 [Pharmaceutical preparations specially antidepressive, antipyretic, analgesic, anesthetics, antiallergic, antihistamine, antidote, detoxicates, antialcoholic, drugs against the smoked, namely, smoking cessation, inhalants, analeptics, hypocholesterolemic, antihemorrhoidal, capillary antifragilizadores, peripheric and cerebral vasodilators, corticosteroids, gastrointestinal, antiacid, antidiarrheal, antihelminthic, emetics and antiemetics, antiulcerous, antiflatulent, digestive antidyspeptic, laxatives, purgative, geriatrics, antifertility drugs and luteolytics, antiasthenics, energetics, antidiabetic, catabolics, antiobesity, anorexics, regulators of the metabolism, neurological central and peripherics system, parasympathomimetics, antiepileptic, medications against Parkinson diseases, hypnotic sedatives, neuroleptics, antiprolactinic, tranquilizing, antisicotic, tymoanaleptic, psychotonics, neurotropic, hormones, estrogenic, progestogenic, contraceptive, androgens, antihormones, antispasmodic, urogenital, antihypertensives, antiarrhyhthmics, anxiolytics, antipsychotics; pharmaceutical preparations for smoking cessation; pharmaceutical preparations for the treatment of insomnia, addiction, eating disorders, cognition, depression, and pain] *Pharmaceutical preparations for the neurological central system, pharmaceutical preparations for the treatment of insomnia.*

ID: 1379049152